Opendata, web and dolomites

NeuronAgeScreen SIGNED

A Drug Discovery and Target Identification Screening Platform for Age-Associated Neurodegenerative Disorders

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NeuronAgeScreen project word cloud

Explore the words cloud of the NeuronAgeScreen project. It provides you a very rough idea of what is the project "NeuronAgeScreen" about.

precisely    battling    manipulation    function    populations    attractive    neuronal    490    disease    marked    societal    organisms    decrease    manifested    platform    devastating    pervasive    throughput    protection    therapeutic    commercialization    evolutionary    parkinson    demonstration    billion    strategies    interventions    nervous    convenient    genetic    experimental    525    compound    streamlining    drug    facets    diseases    dementia    nature    types    combating    ipr    ataxias    enterprise    efficient    erc    human    linked    521    screening    pathologies    neuronage    conserved    discovery    neurodegeneration    ageing    maladies    susceptibility    betterment    file    stage    overarching    platforms    readily    stroke    innovation    neurons    genes    global    combines    model    offers    technologies    uniquely    intervention    health    devising    organism    quality    213    elegans    universally    context    prowess    nematode    microfluidics    vivo    alzheimer    course    dissected    dependability    intimately    life    identification    imaging    prevalence    neurodegenerative    pressing    disorders    patent    versatile    malleable    chemical    innovative   

Project "NeuronAgeScreen" data sheet

The following table provides information about the project.

Coordinator
IDRYMA TECHNOLOGIAS KAI EREVNAS 

Organization address
address: N PLASTIRA STR 100
city: IRAKLEIO
postcode: 70013
website: www.forth.gr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Greece [EL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IDRYMA TECHNOLOGIAS KAI EREVNAS EL (IRAKLEIO) coordinator 150˙000.00

Map

 Project objective

Battling human neurodegenerative pathologies, and their pervasive societal impact, is a global multi-billion Euro enterprise. Ageing is universally associated with marked decrease of neuronal function and higher susceptibility to neurodegeneration. In human populations, this is manifested as an ever-increasing prevalence of devastating neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease, stroke, several ataxias, and other types of dementia. Development of therapeutic interventions against such maladies is becoming a pressing priority. Drug discovery and drug target identification are two intimately linked facets of intervention strategies aimed at effectively combating human disorders. Genes linked to human diseases often function in evolutionary conserved pathways, readily dissected in simple model organisms. Such organisms provide attractive platforms for devising and streamlining efficient drug discovery and target identification methodologies. During the course of the ERC project NeuronAge, we developed a convenient and versatile platform for high-throughput chemical compound screening based on the nematode C. elegans (Nature 521: 525; Nature 490: 213). This innovative platform uniquely combines state-of-the-art microfluidics technologies for imaging and manipulation of neurons in vivo, with the experimental prowess of C. elegans, a highly malleable genetic model, which offers a precisely defined nervous system, two features that are not available in any other organism. We propose to: (1) bring this high-throughput compound screening system to pre-demonstration stage; (2) evaluate its dependability for drug target identification and drug discovery; (3) file US and European patent applications for IPR protection; and (4) identify potential commercialization opportunities. The overarching aim is to facilitate the exploitation of the innovation generated in the context of NeuronAge towards the betterment of human health and quality of life.

 Publications

year authors and title journal last update
List of publications.
2018 Athanasios Metaxakis, Dionysia Petratou, Nektarios Tavernarakis
Multimodal sensory processing in Caenorhabditis elegans
published pages: 180049, ISSN: 2046-2441, DOI: 10.1098/rsob.180049
Open Biology 8/6 2019-05-23
2018 Athanasios Metaxakis, Christina Ploumi, Nektarios Tavernarakis
Autophagy in Age-Associated Neurodegeneration
published pages: 37, ISSN: 2073-4409, DOI: 10.3390/cells7050037
Cells 7/5 2019-05-23
2018 Ioanna Daskalaki, Ilias Gkikas, Nektarios Tavernarakis
Hypoxia and Selective Autophagy in Cancer Development and Therapy
published pages: , ISSN: 2296-634X, DOI: 10.3389/fcell.2018.00104
Frontiers in Cell and Developmental Biology 6 2019-05-23
2018 Vassiliki Nikoletopoulou, Nektarios Tavernarakis
Regulation and Roles of Autophagy at Synapses
published pages: 646-661, ISSN: 0962-8924, DOI: 10.1016/j.tcb.2018.03.006
Trends in Cell Biology 28/8 2019-05-23
2018 Ilias Gkikas, Konstantinos Palikaras, Nektarios Tavernarakis
The Role of Mitophagy in Innate Immunity
published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.01283
Frontiers in Immunology 9 2019-05-23
2018 Nikos Kourtis, Nektarios Tavernarakis
Small heat shock proteins and neurodegeneration: recent developments
published pages: 94-102, ISSN: 1868-5021, DOI: 10.1515/bmc-2018-0009
Biomolecular Concepts 9/1 2019-05-23
2018 Matthias Rieckher, Maria Markaki, Andrea Princz, Björn Schumacher, Nektarios Tavernarakis
Maintenance of Proteostasis by P Body-Mediated Regulation of eIF4E Availability during Aging in Caenorhabditis elegans
published pages: 199-211.e6, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2018.09.009
Cell Reports 25/1 2019-05-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEURONAGESCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEURONAGESCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PROGRESS (2019)

The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

SuperH (2019)

Discovery and Characterization of Hydrogen-Based High-Temperature Superconductors

Read More  

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More